September 2026
The U.S. diabetic foot ulcer treatment market generated USD 3.87 billion in 2026, with prominent U.S. diabetic foot ulcer treatment market companies including 3M / Solventum, Smith+Nephew, Mölnlycke Health Care.
February 2026
The global diabetic foot ulcer treatment market size is projected to hit around USD 17.06 billion by 2035 from USD 9.67 billion in 2025 with a CAGR of 5.84%.
February 2026
The North America diabetic foot ulcer treatment market size is projected to hit around USD 9.31 billion by 2035 from USD 5.22 billion in 2025, with a CAGR of 5.96%.
September 2026
The U.S. systemic inflammatory response syndrome treatment market generated USD 5.28 billion in 2026, with prominent U.S. systemic inflammatory response syndrome treatment market companies including GlaxoSmithKline, AstraZeneca, CytoSorbents Corporation.
September 2026
The U.S. non-invasive aesthetic treatment market size totalled USD 8.72 billion in 2026, with major U.S. non-invasive aesthetic treatment market players including galderma sa, allergen, alma lasers, lumenis, merz pharma.
June 2026
The global mouth ulcer treatment market size was calculated at USD 1.68 billion in 2025 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
February 2026
The global diabetic footwear market size reached USD 9.68 billion in 2025 and is projected to hit around USD 19.85 billion by 2035 with a CAGR of 7.45%.
June 2025
The U.S. water and wastewater treatment market size is estimated to hit around USD 123.76 billion by 2034, increasing from USD 64.27 billion in 2024, with a CAGR of 6.80%.
September 2026
The U.S. DNA synthesis market generated USD 2.30 billion in 2026, with prominent U.S. DNA synthesis market companies including LGC Biosearch Technologie, Bioneer Corporation, Thermo Fisher Scientific, Inc.
September 2026
The U.S. regenerative medicine market was worth USD 24.10 billion in 2026, with key U.S. regenerative medicine market players including Integra LifeSciences Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), American CryoStem Corporation (U.S.).
September 2026
The U.S. clinical trial supply and logistics market was worth USD 1.66 billion in 2026, with key U.S. clinical trial supply and logistics market players including Marken, World Courier, Fisher Clinical Services.
August 2026
The U.S. blood pressure monitoring devices market size reached USD 775.58 billion in 2026, with leading U.S. blood pressure monitoring devices market companies including Koninklijke Philips N.V., General Electric Company, SunTech Medical, Inc.
June 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The U.S. pharmacy automation market was worth USD 2.19 billion in 2026, with key U.S. pharmacy automation market players including Touchpoint Medical, Talyst, LLC (Swisslog Healthcare), Swisslog Healthcare, Scriptpro LLC, Pearson Medical Technologies.
September 2026
The U.S. electron microscopy market was worth USD 1.50 billion in 2026, with key U.S. electron microscopy market players including Olympus Corporation, Nikon Corporation, Leica Microsystems GmbH.
September 2026
The U.S. brachytherapy market was worth USD 370.79 million in 2026, with key U.S. brachytherapy market players including Becton Dickinson & Co, Eckert & Ziegler Bebig SA, Elekta AB ADR.
September 2026
The U.S. bone grafts and substitutes market was valued at USD 01.38 billion in 2026, with leading companies including SeaSpine, AlloSource, Bioventus.
September 2026
The U.S. infant incubator market size stood at USD 224.31 million in 2026, with major U.S. infant incubator market companies including Cardinal Health, Dragerwerk AG & Co. KGaA, GE Healthcare.
September 2026
The U.S active pharmaceutical ingredients market size stood at USD 44.46 billion in 2026, with major U.S active pharmaceutical ingredients market companies including AbbVie Inc, Viatris Inc, Fresenius Kabi AG.
September 2026
The U.S. environmental remediation market was worth USD 24.87 billion in 2026, with key U.S. environmental remediation market players including Clean Harbors, AECOM, Tetra Tech
September 2026
The U.S. cardiovascular drugs market was valued at USD 29.25 billion in 2026, with leading companies including Bristol-Myers Squibb, Bayer AG, Pfizer Inc.
September 2026
The U.S. biosensors market was valued at USD 11.69 billion in 2026, with leading companies including Abbott Laboratories, Dexcom Inc., Bio-Rad Laboratories, Inc.
September 2026
The U.S. pharmaceutical water market was valued at USD 8.66 billion in 2026, with leading companies including Veolia Water Technologies, Thermo Fisher Scientific, Danaher Corporation, Merck KGaA.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
September 2026
The U.S. cosmeceuticals market size stood at USD 17.58 billion in 2026, with major U.S. cosmeceuticals market companies including Avon, Estee Lauder, Johnson and Johnson.
September 2026
The U.S. buy now pay later market reached USD 6.01 billion in 2026, with key U.S. buy now pay later companies including sizzle, zip co limited, splitit payments ltd, affirm holdings inc, paypal holdings inc, perpay.
September 2026
The U.S. pharmacy benefit management market was valued at USD 504.08 billion in 2026, with leading companies including Cigna Group, CVS Health, MedImpact.
September 2026
The U.S. pain management drugs market reached USD 33.84 billion in 2026, with key U.S. pain management drugs companies including abbott, Pfizer, teva pharmaceutical, endo international, depomed, merck.
September 2026
The Healthcare Consumables market was valued at USD 49.33 billion in 2026, with leading companies including boston scientific corporation, 3m, johnson & johnson, Medtronic, bd.
September 2026
The U.S. insulin pump market generated USD 2.48 billion in 2026, with prominent U.S. insulin pump market companies including Medzer, Cequr SA, Medtronic.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com